Skip to main content

Table 1 Background characteristics of the study population

From: The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers

Variable N = 109 Group P value
Suboptimal cytoreduction Optimal cytoreduction
N = 56 N = 53
Age (years) 0.269
 Mean ± Std 47.48 ± 11.347 48.66 ± 9.648 46.24 ± 12.880  
 Median 47.00 47.00 47.00  
 Range (min–max) 17/00–75.00 26.00–64.00 17.00–75.00  
Parity 0.261
 0 28 (25.7%) 16 (28.6%) 12 (22.6%)  
 1 16 (14.7%) 6 (10.7%) 10 (18.9%)  
 2 23 (21.1%) 15 (26.8%) 8 (15.1%)  
   > 3 42 (38.5%) 19 (33.9%) 23 (43.4%)  
IMT 0.353
 Mean ± Std 21.30 ± 3.907 20.96 ± 3.675 21.66 ± 4.143  
 Median 21.30 21.25 21.40  
Ascites 0.089
 Mean ± Std 1652.56 ± 3664.119 1703.75 ± 3393.296 1598.49 ± 3962.289  
 Median 300.00 400.00 300.00  
Stage 0.0001
 II 42 (38.5%) 8 (14.3%) 34 (64.2%)  
 III 57 (52.3%) 38 (67.9%) 19 (35.8%)  
 IV 10 (9.2%) 10 (17.9%) 0 (0.0%)  
Histopathology 0.559
 Serous 27 (24.8%) 18 (32.1%) 9 (17.0%)  
 Mucinous 38 (34.9%) 12 (21.4%) 26 (49.1%)  
 Endometrioid 21 (19.3%) 14 (25.0%) 7 (13.2%)  
 Clear cell 16 (14.7%) 8 (14.3%) 8 (15.1%)  
 Others 7 (6.4%) 4 (7.1%) 3 (5.7%)  
\